NEM NEWMONT Corp /DE/ Insider Trading

Interim CFO Peter Wexler sells 23,786 shares (16.5% of position) for $2.6M in first open-market sale.

Peter Wexler, Executive Vice President, Chief Legal Officer and Interim CFO, sold roughly one-sixth of his shareholding in a single transaction, disposing of over $2.5M in company stock. This is his first open-market sale in the past three years—all prior insider activity had been equity compensation transactions. The sale occurred when the stock was trading well below its 52-week high, at a price point where the company remains profitable and still generating positive earnings per share. Without prior open-market sales to establish a pattern, this inaugural disposal stands out as a notable liquidity event for a senior executive holding direct operational responsibility for the company's finances and legal affairs. The size and nature of the transaction—converting a meaningful portion of vested compensation into cash—merits attention, though the lack of a repeat-seller pattern or contextual catalysts limits definitive interpretation of executive conviction.

Newmont Group Head Projects & Studies Fry sells 18,394 shares at $111.45; holdings cut by 51.8% to 17,147 shares post-transaction.

David James Fry, Group Head Projects & Studies at Newmont, executed a single open-market sale of 18,394 shares at $111.45 on 2026-03-16, reducing his holdings from 35,541 shares to 17,147 shares—a 51.8% reduction. The sale price of $111.45 was 4.5% above the current price of $106.54 but 15.5% below the 52-week high of $131.95, placing the transaction within a broader context of the stock's -19.3% decline from its recent peak. While the company shows solid operational fundamentals with $5.5B in quarterly revenue, 21.3% annual revenue growth, and a $1.8B net income, the substantial reduction in Fry's personal stake—disposing of more than half his holdings—represents a material shift in his equity position that investors should track relative to subsequent company announcements and insider activity.

Then-CEO Palmer Thomas Ronald sold 13,000 NEM shares at $41.59 via pre-arranged 10b5-1 plan

Palmer Thomas Ronald, who was President & CEO at the time of this filing, sold 13,000 shares (13.0K shares) of NEWMONT Corp /DE/ (NEM) at $41.59 on 2024-12-02 under a pre-arranged 10b5-1 trading plan, reducing his holdings from 258,469 shares (258.5K shares) to 245,469 shares (245.5K shares), a decrease of 5.0% versus pre-transaction holdings. Because this transaction was part of a scheduled 10b5-1 trading plan rather than discretionary, the timing and execution reflect a predetermined schedule established in advance, not a response to current market conditions or company fundamentals. The sale itself represents a routine portfolio adjustment by a departing executive, with no material signaling value regarding his conviction in the company's near-term prospects.

Director Conger buys 9,498 NEM shares at $42.15 on 2024-11-27; stock now $40.91, down 30.3% from 52-week high

Director Harry M. Conger IV purchased 9,498 shares of Newmont Corp on 2024-11-27 at $42.15, tripling his holdings from 5,000 to 14,498 shares. The purchase occurred while the stock trades 30.3% below its 52-week high of $58.68 and has declined 21.7% over the past 90 days. Notably, the company reported full-year net income was negative in its most recent fiscal year, making this a director-level equity commitment at a time of profitability pressure and downward price momentum. The material increase in personal exposure—a 190.0% increase in shareholdings—occurred in a period of significant stock weakness rather than momentum.

NEM CEO Palmer Thomas Ronald sells 13,000 shares at $45.45; stock -21.6% from 52-week high, down -13.8% in 30 days

Palmer Thomas Ronald, President & CEO of Newmont, sold 13,000 shares (13.0K shares) for $590,850.00 ($590.8K) on 2024-11-01 at $45.45, reducing his holdings by 4.8% to 258,469 shares (258.5K shares). The timing coincides with material price weakness: the stock is -21.6% from its 52-week high of $58.68 and has declined -13.8% over the past 30 days, trading $0.55 below the transaction price. His prior trades at NEM show mixed timing results: 2 of 3 measurable 90-day outcomes were well-timed (stock fell after the sale), though one recent sale on 2024-10-01 experienced a -15.6% 30-day decline post-sale. The fundamental backdrop reflects headwinds: the company reported annual revenue decline of -0.9% and was unprofitable over the most recent full fiscal year, with net income negative despite the latest quarter showing $922.0M in net income. This sale occurs during a period of deteriorating stock price and negative annual growth, making it factually observable but without clear forward signals beyond current market conditions.

CEO Palmer Thomas Ronald sold 20,000 NEM shares at $53.81 on 2024-10-01; stock now $53.20, -4.7% from 52-week high.

Palmer Thomas Ronald, President & CEO of Newmont, executed a sale of 20,000 shares (20.0K shares) at $53.81, reducing his holdings by 6.9% to 271,469 shares (271.5K shares). The sale occurred near the 52-week high, with the stock currently $0.61 below the transaction price at $53.20. His prior sales at this ticker show mixed timing outcomes: 2 of 3 measurable 90-day periods were well-timed (negative returns after sale), but his 2023 sales coincided with subsequent declines of -11.2% and -12.8%, whereas his 2024 sales through July showed strong post-sale gains of +16.5% at 90 days. Current fundamental context includes flat annual revenue growth at -0.9% and full-year net income losses, though the latest quarterly net income was positive at $853,000,000.

CEO Palmer sold 20,000 NEM shares at $52.47; holdings now 291.5K shares. Stock +28.7% in 90 days.

Palmer Thomas Ronald, President & CEO, executed a discretionary sale of 20,000 shares at $52.47 on 2024-09-03, reducing his holdings to 291.5K shares from 311.5K shares (a 6.4% reduction). The sale occurred near the 52-week high of $53.39, with the stock up 28.7% over the prior 90 days and 9.1% over the prior 30 days. At the same ticker, Palmer's prior two measurable sales (May 2023 and April 2023) exhibited 90-day declines of -11.2% and -12.8% respectively, establishing a 2-of-2 well-timed pattern at NEM. However, his cross-ticker track record shows an average 90-day return of -12.0% post-sale with a 100% well-timed rate, suggesting his sales have historically preceded stock declines. The company generated $4.4B in quarterly revenue but was unprofitable over its most recent full fiscal year, with annual revenue growth of -0.9%, creating a backdrop where insider sales near cyclical highs warrant investor attention.

Palmer Thomas Ronald (CEO) sold 20,000 shares of NEM at $49.51; stock down 5.1% from 52-week high.

Palmer Thomas Ronald, President & CEO, sold 20,000 shares (311.5K shares remaining post-transaction) on 2024-08-01 at $49.51, near the 52-week high of $49.55. His prior NEM-specific sales on 2024-07-01 and 2023-05-01 both showed negative 90-day returns, indicating a 2 of 2 well-timed pattern at this ticker. However, the company reported unprofitable full-year results with annual revenue decline of -0.9%, and Q3 fundamentals show $4.4B quarterly revenue with $853.0M net income yet negative annual net income. The sale occurs in a context of weak fundamentals, though the stock has recovered 5.7% over the past 30 days and 13.5% over 90 days from depressed levels.

CEO Palmer Thomas Ronald sells 13,000 NEM shares at $42.13; prior same-ticker sells well-timed with 90d declines.

Palmer Thomas Ronald, President & CEO of Newmont Corp, sold 13,000 shares (13.0K shares) on 2024-07-01 at $42.13, reducing holdings by 3.8% from 344.5K to 331.5K shares. His prior trades at NEM show a consistent timing pattern: both of his 2 prior sells at this ticker were followed by negative 90-day returns (-11.2% and -12.8%), suggesting he has historically sold ahead of declines. The current stock price of $43.45 sits 4.4% below the 52-week high and in positive territory on a 30-day and 90-day basis (+3.7% and +15.2%), contrasting with the historical pattern where his previous sales preceded downturns. The company reported negative full-year net income and flat annual revenue growth (-0.9%), providing a backdrop of constrained fundamentals that investors should monitor against near-term price strength.